KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →

EPO controversy

The recent controversy on EPO is leaving doctors in a no-win situation:

John Glaspy, an oncologist and professor of medicine at UCLA, says that for patients with falling hemoglobin – a critical protein carried by red blood cells — doctors must face a quandary. “When we see a patient whose hemoglobin is falling, there is a theoretical risk if we do something – blood clots and possible effect on survival – and a risk if we don’t do something: transfusions and symptoms like fatigue, shortness of breath and chest pain,”

“Doctors feel concerned and unguided, because the black-box warning makes them feel vulnerable and at risk to be criticized after the fact,” he says. He adds that he doesn’t feel the drugs are commonly over-prescribed.

Ed Silverman thinks it’s about the money. Maybe, but you just have to accept that sometimes medicine is practiced in shades of gray, not black and white.

Share this articleLinkedInFacebookXEmail

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.